University of California, San Francisco (UCSF)
About University of California, San Francisco (UCSF)
Check out the link below for more information on biotechnolgy-related research at UCSF.
603 articles with University of California, San Francisco (UCSF)
-
BETting On COVID-19: Study Probes Role of BET Proteins in Coronavirus Infection
7/19/2022
A while ago, some researchers had suggested that blocking a set of proteins, known as bromodomain and extraterminal proteins, might be a way to fight COVID-19.
-
The American Society of Clinical Oncology and the Association of Community Cancer Centers are combining their efforts to increase racial and ethnic diversity in clinical trials.
-
Kirstin Bibbins-Domingo takes over on July 1 and will become the first African American to helm the prestigious medical journal.
-
BMS partnered with digital oncology company GRYT Health to convene a series of “courageous conversations” between patients, practitioners, caregivers, clinical trial teams and public health leaders.
-
Arc begins its mission with $650 million in donations from donors. This funding will sustain the scientists and their researchers over renewable eight-year terms.
-
Frontier Medicines will support the continued development of the company’s chemoproteomics drug discovery program, including lead asset, an inhibitor of KRASG12C.
-
The device is at the core of the BRAVO trial, which evaluates signals to control complex devices for motor and speech in adults who have been severely affected by neurological disorders.
-
Drug companies have been suggesting that booster shots will be needed. However, it is up to the CDC's recommendation if booster shots are necessary.
-
Cambia Health Foundation Invests $1.5M in UCSF Division of Palliative Medicine to Improve Serious Illness Care through Innovation, Leadership and Collaboration
8/25/2020
New Foundation grant to fund innovative projects, national convenings and education programs that will enhance the skills of all health care providers and improve the experience of patients
-
They are approximately 25% of the size of human antibodies and from other animals, and they appear to be the most potent anti-coronavirus compound that has been tested in the laboratory so far.
-
A research team may have discovered a means to prevent breast cancer from spreading to other parts of the body through the blocking of a single enzyme.
-
Weill Neurohub Will Promote Cross-Institutional Collaboration in Brain Trauma and Neurodegenerati...
11/13/2019
The Weill Family Foundation, University of California, Berkeley, University of California, San Francisco and the University of Washington launched the Weill Neurohub with a $106 million gift. -
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Researchers at the University of California at San Francisco have discovered that a scorpion toxin can actually be harnessed to target the wasabi receptor, which is described as a “chemical-sensing protein” found in nerve cells.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
When Becky Fu met Brett Robb at a CRISPR conference four years ago, they were both deeply involved in CRISPR. The two published a paper in March in Nature Microbiology on the subject and on Fu’s findings on the complex mechanisms of the Cpf1 nucleases, a different set of enzymes than the often-us...
-
Recently, we interviewed Bill Lindstaedt, who is the Assistant Vice Chancellor of Career Advancement, International and Postdoctoral Services at the University of California San Francisco. If you’ve ever wanted more information from an expert on careers in the life sciences, reviewing his career ...
-
AFM, a polio-like condition, has infected more than 500 children since 2014. Scientists may have discovered the root of the disease.
-
Here are some of the top research stories that happened around the industry this week.
-
Tmunity and UC San Francisco Announce Exclusive License and Research Collaboration to Advance TCR T Cell Therapies for Pediatric Cancers
5/1/2019
Collaboration will broaden Tmunity’s pipeline to include a glioma T cell therapy engineered to express a newly discovered T cell receptor